| 英文名稱 |
中文名稱 |
CAS號(hào) |
操作 |
| 4-fluoro-N-(1-methylpiperidin-4-yl)benzamide |
4-氟-N-(4-(1-甲基哌啶))苯甲酰胺 |
210643-93-9 |
詳細(xì)
|
| NP3-253 |
|
2557349-50-3 |
詳細(xì)
|
| PT-2385 |
|
1672665-49-4 |
詳細(xì)
|
| DNL-758;SAR-443122;Eclitasertib，5-benzyl-N-[(3S)-5-methyl-4-oxo-2,3,4,5-tetrahydropyrido[3,2-b][1,4]oxazepin-3-yl]-2H-1,2,4-triazole-3-carboxamide |
5-芐基-N-[(3S)-5-甲基-4-氧亞基-2,3,4,5-四氫吡啶并[3,2-b][1,4]氧雜氮雜環(huán)庚熳-3-基]-2H-1,2,4-三氮雜環(huán)戊熳-3-甲酰胺 |
2125450-76-0 |
詳細(xì)
|
| ZM-H1505R; Canocapavir |
卡農(nóng)克韋 |
2137847-19-7 |
詳細(xì)
|
| IDEAYA-1 |
|
2882953-29-7 |
詳細(xì)
|
| MRT-6160 |
|
3050683-38-7 |
詳細(xì)
|
| Givinostat |
4-[(羥基氨基)羰基]苯基]氨基甲酸 [6-[(二乙基氨基)甲基]-2-萘基]甲酯 |
497833-27-9 |
詳細(xì)
|
| Selinexor; KPT-330 |
塞利尼索 |
1393477-72-9 |
詳細(xì)
|
| Eganelisib; IPI-549 |
依加利塞 |
1693758-51-8 |
詳細(xì)
|
| AZD1390 |
|
2089288-03-7 |
詳細(xì)
|
| 2-Fluorobiphenyl-4-carboxylic acid |
2-氟聯(lián)苯基-4-羧酸 |
137045-30-8 |
詳細(xì)
|
| N-(4-Bromo-2-fluorobenzoyl)morpholine |
N-(4-溴-2-氟苯甲?；?嗎啉 |
924642-61-5 |
詳細(xì)
|
| 2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)aniline |
2-甲氧基-3-(1-甲基-1H-1,2,4-三唑-3-基)苯胺 |
1609394-10-6 |
詳細(xì)
|
| AZD0156 |
|
1821428-35-6 |
詳細(xì)
|
| 4,6-dichloro-N-(methyl-d3)pyridazine-3-carboxamide |
4,6-二氯-N-(甲基-d3)-3-噠嗪甲酰胺 |
1609393-89-6 |
詳細(xì)
|
| (R)-N-(5-((5-(4-acryloyl-3-methyl-1,4-diazepane-1-carbonyl)-4-methoxy-2-methylphenyl)thio)thiazol-2-yl)cyclopropanecarboxamide |
Soquelitinib；CPI-818 |
2226636-04-8 |
詳細(xì)
|
| Lunresertib; RP-6306 |
|
2719793-90-3 |
詳細(xì)
|
| AGI-43192 |
|
2377491-54-6 |
詳細(xì)
|
| AZD4144 |
|
2890191-41-8 |
詳細(xì)
|
| 2-Methoxy-5-(trifluoromethyl)phenol |
2-甲氧基-5-三氟甲基苯酚 |
349-67-7 |
詳細(xì)
|
| 4-Bromo-2-fluoro-n-methoxy-n-methylbenzamide |
4-溴-2-氟-N-甲氧基-N-甲基苯甲酰胺 |
801303-33-3 |
詳細(xì)
|
| tert-butyl (R)-3-methyl-1,4-diazepane-1-carboxylate |
(R)-1-Boc-2-甲基-[1,4]二氮雜環(huán)庚烷 |
223644-10-8 |
詳細(xì)
|
| CFI-402257 |
|
1610759-22-2 |
詳細(xì)
|
| 2-Methoxy-4-(Trifluoromethyl)Phenol |
2-甲氧基-4-(三氟甲基)苯酚 |
1027888-79-4 |
詳細(xì)
|
| NX-1607 |
|
2573775-59-2 |
詳細(xì)
|
| AK-1690 |
|
2984505-88-4 |
詳細(xì)
|
| BMS-986299 |
|
2242952-69-6 |
詳細(xì)
|
| Osunprotafib; ABBV-CLS-484; AC484 |
|
2489404-97-7 |
詳細(xì)
|
| BMS-502 |
|
2407854-18-4 |
詳細(xì)
|
| GSK2982772，5-benzyl-N-[(3S)-5-methyl-4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]oxazepin-3-yl]-2H-1,2,4-triazole-3-carboxamide |
5-芐基-N-[(3S)-5-甲基-4-氧亞基-2,3,4,5-四氫苯并[b][1,4]氧雜氮雜環(huán)庚熳-3-基]-2H-1,2,4-三氮雜環(huán)戊熳-3-甲酰胺 |
1622848-92-3 |
詳細(xì)
|
| AG-270; S-095033 |
|
2201056-66-6 |
詳細(xì)
|
| XD2-149 |
|
2710221-08-0 |
詳細(xì)
|
| 2-Fluoro-4-iodobenzonitrile |
2-氟-4-碘苯腈 |
137553-42-5 |
詳細(xì)
|
| NDI-091143 |
|
2375840-87-0 |
詳細(xì)
|
| Ensitrelvir |
S-217622 |
1471484-62-4 |
詳細(xì)
|
| 5-methylsulfanylpyrimidin-2-amine |
2-氨基-5-甲硫基嘧啶 |
7367-94-4 |
詳細(xì)
|
| RI962，1-methyl-5-{2-[(2-methylpropanoyl)amino][1,2,4]triazolo[1,5-a]pyridin-7-yl}-N-(1-phenylethyl)indole-3-carboxamide |
1-甲基-5-{2-[(2-甲基丙?；?氨基][1,2,4]三氮雜環(huán)戊熳并[1,5-a]吡啶-7-基}-N-(1-苯基乙基)吲哚-3-甲酰胺 |
2763831-53-2 |
詳細(xì)
|
| IDEAYA-4 |
|
2782815-65-8 |
詳細(xì)
|
| Deucravacitinib |
氘可來替西尼 |
1609394-05-9 |
詳細(xì)
|
| LP-935509 |
|
1454555-29-3 |
詳細(xì)
|
| 4,6-Dichloro-N-methylnicotinamide |
4,6-二氯-N-甲基煙酰胺 |
1609530-95-1 |
詳細(xì)
|
| Pentanamide |
BMS-911172 |
1644248-18-9 |
詳細(xì)
|
| JBI-589 |
|
2308504-22-3 |
詳細(xì)
|
| 4-Bromo-2-fluoro-N,N-dimethylbenzamide |
4-溴-2-氟-N,N-二甲基苯甲酰胺 |
749927-80-8 |
詳細(xì)
|
| 4-Bromo-N-cyclopropyl-2-fluorobenzamide |
4-溴-N-環(huán)丙基-2-氟苯甲酰胺 |
877383-84-1 |
詳細(xì)
|
| Dapansutrile; OLT-1177 |
達(dá)泮舒腈 |
54863-37-5 |
詳細(xì)
|
| 4-Hydroxy-3-(trifluoromethoxy)benzonitrile |
4-羥基-3-(三氟甲氧基)芐腈 |
1093397-72-8 |
詳細(xì)
|
| 2-Nitro-4-(trifluoromethyl)benzyl alcohol |
2-硝基-4-(三氟甲基)芐醇 |
133605-27-3 |
詳細(xì)
|
| Emlenoflast; MCC7840 |
|
1995067-59-8 |
詳細(xì)
|
| AZ-28 |
|
2439271-82-4 |
詳細(xì)
|
| N-(2-ethynyl-5-(trifluoromethyl)phenyl)acetamide |
N-(2-乙基-5-(三氟甲基)苯基)醋胺 |
1436417-15-0 |
詳細(xì)
|
| RO-7623066; RG-6614; KSQ-4279 |
|
2446480-97-1 |
詳細(xì)
|